Terms: = Lung cancer AND COL2A1, SEDC, MGC131516, COL11A3, AOM, ANFH, ENSG00000139219, 1280 AND Staging
4 results:
1. Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial.
Felip E; Altorki N; Zhou C; Csőszi T; Vynnychenko I; Goloborodko O; Luft A; Akopov A; Martinez-Marti A; Kenmotsu H; Chen YM; Chella A; Sugawara S; Voong D; Wu F; Yi J; Deng Y; McCleland M; Bennett E; Gitlitz B; Wakelee H;
Lancet; 2021 Oct; 398(10308):1344-1357. PubMed ID: 34555333
[TBL] [Abstract] [Full Text] [Related]
2. Improved non-invasive T-staging in non-small cell lung cancer by integrated 18F-FDG PET/CT.
Pauls S; Buck AK; Hohl K; Halter G; Hetzel M; Blumstein NM; Mottaghy FM; Glatting G; Krüger S; Sunder-Plassmann L; Möller P; Hombach V; Brambs HJ; Reske SN
Nuklearmedizin; 2007; 46(1):9-14; quiz N1-2. PubMed ID: 17299649
[TBL] [Abstract] [Full Text] [Related]
3. In vitro and in vivo treatment of colon cancer by VIP antagonists.
Levy A; Gal R; Granoth R; Dreznik Z; Fridkin M; Gozes I
Regul Pept; 2002 Nov; 109(1-3):127-33. PubMed ID: 12409224
[TBL] [Abstract] [Full Text] [Related]
4. [A study of 75 untreated lung cancers in the elderly].
Kawahata N; Sawaguchi Y; Ohtomo E; Hayakawa M; Yamaoka M; Matsuse T; Fukuchi Y
Nihon Ronen Igakkai Zasshi; 1989 Sep; 26(5):462-8. PubMed ID: 2559220
[TBL] [Abstract] [Full Text] [Related]
